Clinical Trial Results:
In vivo effects of C1-esterase inhibitor on innate immune response during endotoxemia in human - VECTOR-II study
A randomized controlled pilot study
Summary
|
|
EudraCT number |
2011-002222-46 |
Trial protocol |
NL |
Global completion date |
21 Dec 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Jun 2022
|
First version publication date |
10 Jun 2022
|
Other versions |
|
Summary report(s) |
Article |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.